Non Potluck Post 2 Carly
Johnson
Glioblastoma
multiforme (GBM) is one of the most aggressive tumors to the central
nervous system, giving the afflicted patients on average only about 5
year survival rate and only 5% recovery prognosis. This paper highlights a
new view into the treatment of gliblastoma tumors, by using cultured
neural stem cells in the mammalian CNS. This study hopes for the invention
of novel therapeutic targets and pathways for GBM based on the development
of single cell-transcription and epigenmone analysis by way of epigenmonic
change delineation associated with GMB tumors.
Bing Yao,
Peng Jin
Genome
Biology201819:51
© The Author(s). 2018
Published: 10 April 2018
No comments:
Post a Comment